Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kuopio

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cancer Research|February 11, 1998
Cysteine proteinase inhibitor cystatin A in breast cancerT Kuopio, A Kankaanranta, P Jalava, et al.
Breast Cancer Research and Treatment|November 26, 1999
Immunohistochemical labelling for prostate-specific antigen in breast carcinomasK A Alanen, T Kuopio, Y U Collan, et al.
British Journal of Cancer|July 2, 1999
Characterization of the model for experimental testicular teratoma in 129/SvJ-miceJ Sundström, L J Pelliniemi, T Kuopio, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 18, 2016
Prognostic implications of securin expression and sub-cellular localization in human breast cancerN Gurvits, H Repo, E Löyttyniemi, et al.
The American Journal of Pathology|February 13, 2001
Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesisL Nelimarkka, H Salminen, T Kuopio, et al.
British Journal of Cancer|August 20, 2009
Securin promotes the identification of favourable outcome in invasive breast cancerK Talvinen, H Karra, S Hurme, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|December 18, 2001
Time course of female-to-male sex reversal in 38,XX fetal and postnatal pigsE Pailhoux, P Parma, J Sundström, et al.
British Journal of Cancer|May 24, 2014
Cdc20 and securin overexpression predict short-term breast cancer survivalH Karra, H Repo, I Ahonen, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2010
Altered expression of p120catenin predicts poor outcome in invasive breast cancerK Talvinen, J Tuikkala, M Nykänen, et al.
Pathology, Research and Practice|September 1, 1996
Standardized mitotic counts in breast cancer. Evaluation of the methodY U Collan, T Kuopio, J P Baak, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cancer Research|February 11, 1998
Cysteine proteinase inhibitor cystatin A in breast cancerT Kuopio, A Kankaanranta, P Jalava, et al.
Breast Cancer Research and Treatment|November 26, 1999
Immunohistochemical labelling for prostate-specific antigen in breast carcinomasK A Alanen, T Kuopio, Y U Collan, et al.
British Journal of Cancer|July 2, 1999
Characterization of the model for experimental testicular teratoma in 129/SvJ-miceJ Sundström, L J Pelliniemi, T Kuopio, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 18, 2016
Prognostic implications of securin expression and sub-cellular localization in human breast cancerN Gurvits, H Repo, E Löyttyniemi, et al.
The American Journal of Pathology|February 13, 2001
Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesisL Nelimarkka, H Salminen, T Kuopio, et al.
British Journal of Cancer|August 20, 2009
Securin promotes the identification of favourable outcome in invasive breast cancerK Talvinen, H Karra, S Hurme, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|December 18, 2001
Time course of female-to-male sex reversal in 38,XX fetal and postnatal pigsE Pailhoux, P Parma, J Sundström, et al.
British Journal of Cancer|May 24, 2014
Cdc20 and securin overexpression predict short-term breast cancer survivalH Karra, H Repo, I Ahonen, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2010
Altered expression of p120catenin predicts poor outcome in invasive breast cancerK Talvinen, J Tuikkala, M Nykänen, et al.
Pathology, Research and Practice|September 1, 1996
Standardized mitotic counts in breast cancer. Evaluation of the methodY U Collan, T Kuopio, J P Baak, et al.
Pageof 5